PharmaVoice 26 mars 2026 How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup
PharmaVoice 16 mars 2026 340B: When the safest move can feel like no move at all. Why “waiting” is no longer a viable strategy
PharmaVoice 10 mars 2026 Executives want in, but researchers want out — how pharma’s US job picture is changing